Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Stair Instead of Elevator Use at Work: Cardiovascular Primary Preventive Effects on Hospital Employees.

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT00520195
First received: August 21, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
  Purpose

This is an intervention study which evaluates the cardiovascular primary preventive effects of using stairs instead of elevators at the worksite during a 12-weeks period. We hypothesize that stair-climbing during working hours can meet the daily amount of physical activity recommended by current public health guidelines.


Condition Intervention
Cardiovascular Diseases
Behavioral: Physical activity

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by University Hospital, Geneva:

Enrollment: 77
Study Start Date: March 2007
Study Completion Date: July 2007
Intervention Details:
    Behavioral: Physical activity
    Climbing stairs instead of taking elevators at worksite during 12 weeks.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Age > 18 years
  • No or little stair-use at work (< 5 stories/day)
  • Sedentary lifestyle

Exclusion Criteria:

  • Positive answers to the health screening physical activity readiness questionnaire (PAR-Q)
  • Part-time employment < 80%
  • Absence of more than 2 weeks during the intervention period
  • Intention to begin a weight control program
  • Medication changes which may influence blood pressure, lipid or glucose metabolism
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00520195

Locations
Switzerland
University Hospitals of Geneva
Geneva, Switzerland, 1211
Sponsors and Collaborators
University Hospital, Geneva
Investigators
Principal Investigator: Philippe Meyer, MD University Hospitals of Geneva
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00520195     History of Changes
Other Study ID Numbers: 06-306 (med06-100)
Study First Received: August 21, 2007
Last Updated: August 21, 2007
Health Authority: Switzerland: Ethikkommission

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on November 20, 2014